Carfilzomib and Dexamethasone in combination with Cyclophosphamide vs. Carfilzomib and dexamethasone in patients with relapsed / refractory multiple myeloma: a randomized controlled phase II clinical trial
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: PETHEMA FOUNDATION
- Phase: II
- Execution start: 20/12/2017
- End of execution: 31/12/2024
- IP: